Evaluation of Urine as an Anti-Tumor Agent after Exercise.

Study on How Exercise Affects Urine

Recruiting
18 years - 100 years
All
1 Location

Brief description of study.

The purpose of this study is to evaluate anti-tumor capabilities of urine with and without physical exercise, and examine linkage of anti-tumor capabilities to the concentrations of cholesterol and dopamine in the urine.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Healthy volunteers.
  • Age: 18 years - 100 years
  • Gender: All

Inclusion:

•    Healthy individuals at 18 or older
•    Can conduct 30-min physical exercise
•    Can provide an appropriate exercise gear

Exclusion:

Any otherwise eligible subject who answers any of the yes/no questions on the modified physical activity readiness questionnaire with a "yes" will excluded from participation.

Updated on 19 Feb 2024. Study ID: 1907143445

This study investigates the anti-tumor capabilities of urine both with and without physical exercise. The study aims to understand how these capabilities might be linked to the concentrations of cholesterol and dopamine in the urine. Cholesterol is a type of fat found in your blood, and dopamine is a chemical in the brain that affects mood and movement.

Participants will be asked to engage in a 30-minute physical exercise session. Urine samples will be collected to analyze the levels of cholesterol and dopamine. The study will compare results from before and after exercise to assess changes in anti-tumor capabilities.

  • Who can participate: Participants must be healthy individuals aged 18 or older who can perform a 30-minute physical exercise and provide appropriate exercise gear. Those answering "yes" to any question on a modified physical activity readiness questionnaire will be excluded.
  • Study details: Participants will need to perform a 30-minute physical exercise and provide urine samples. The samples will be analyzed for cholesterol and dopamine levels to study their anti-tumor capabilities.

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Race
Ethnicity
Other language

Default Content Message Here